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August 2012574 AbstractsParental Intermittent Claudication as Risk Factor for Claudication in
Adults
Prushik SG, Farber A, Gona P, et al. Am J Cardiol 2012;109:736-41.
Conclusion: Intermittent claudication (IC) in parents increases the
risk of IC in adult offspring, independent of established risk factors.
Summary: A consensus statement from the National Institutes of
Health indicates family history is important to patient care because it
contributes information to the risk of developing common diseases, includ-
ing diabetes mellitus, stroke, heart disease, and cancer (Berg AO et al, Ann
Intern Med 2009;151:872-7). For example, parental stroke is associated
with a threefold increase in the risk of stroke in offspring (Seshaderi S et al,
Circulation 2010;121:1304-12). There is, however, little known about
familial aggregation of peripheral arterial disease. The Framingham Heart
Study provides an opportunity to use prospectively collected data from a
large community sample to study IC across two generations. This study
tested the hypothesis that parental IC increases risk of IC in adult offspring.
The authors evaluated the offspring of participants in the FraminghamHeart
Study who were aged30 years, free of cardiovascular disease, and had both
parents enrolled in the Framingham Heart Study (n  2970 unique partic-
ipants, 53% women). The 12-year risk of incidence IC in offspring partici-
pants was associated with parental IC and analyzed using pooled propor-
tional hazard regression analysis and adjusting for age, sex, diabetes,
smoking, systolic blood pressure, total cholesterol, high-density lipoprotein
cholesterol, and antihypertensive and lipid treatment. There were 909
individuals examined in the group with parental IC history and 5,397 in the
group with no parental IC history. There were 101 incident IC events
during follow-up; 29 in the group with parental IC history and 72 in the
group without parental IC history. The age-adjusted and sex-adjusted
12-year cumulative incidence IC rate/1,000 person-years was 5.08 (95%
confidence interval [CI], 2.74-7.33) and 2.34 (95% CI, 1.46-3.19) in
participants with and without a parental IC history. A parental history of IC
increased the risk of incidence IC in offspring (multivariable adjusted hazard
ratio, 1.81; 95% CI, 1.14-2.88). Adjustment for the occurrence of cardio-
vascular disease did not change the hazard ratio.
Comment: The hazard ratio for development of IC in children of
patients with IC was independent of established cardiac risk factors, which
suggests a genetic component or genetic predisposition to IC. The impor-
tance of this potential genetic component in influencing the development of
IC cannot truly be determined from these data. There are assuredly envi-
ronmental and life style factors likely shared within families that could also
contribute to the susceptibility to IC. Limitations to this study include that
IC was diagnosed by symptoms alone and that the risk factors used for
adjustment in the multivariable model were from a single occasion measure-
ment and may not reflect accumulation of lifetime risk factor exposures.
Single Versus Multi-Specialty Operative Teams: AssociationWith Peri-
operative Mortality After Endovascular Abdominal Aortic Aneurysm
Repair
Mazer LM, Chiakof EL, Goodney PP, et al. Am Surg 2012;78:207-12.
Conclusion: Multispecialty participation in endovascular aneurysm
repair (EVAR) is associated with higher 30-day mortality compared with
single-specialty performance of EVAR.
Summary: EVAR is performed by vascular surgeons, interventional
radiologists, interventional cardiologists, general surgeons, cardiovascular
surgeons, and combinations of these. There are theoretic concerns of
multispecialty participation in a surgical procedure. Potential ambiguity
regarding individual physician roles and responsibilities in leadership may
contribute to communication breakdown during the procedure. The au-
thors sought to determine the relative frequency of single-specialty vs
multispecialty EVAR in 2005 to 2008 using the American College of
Surgeons National Surgical Quality Improvement Participant data file. With
these data, they explored the influence of multispecialty EVAR on 30-day
mortality. EVARs were identified and classified as multispecialty or single-
specialty procedures based on Current Procedural Terminology codes.
Baseline and procedural characteristics were compared using 2 or Fisher
exact tests for categoric variables and t tests for continuous variables.
Multivariate logistic regression modeling was used to examine the associa-
tion between multispecialty EVAR and 30-day mortality. They identified
7,269 EVAR procedures; of these 7,086 were performed by a single special-
ist type and 183 were multispecialty. Frequency of brachial or iliac artery
exposure was higher and operative times were longer in multispecialty
patients. Patients were otherwise similar in baseline and procedural charac-
teristics. In the multivariate model, multispecialty EVARwas associated with
an increased risk of 30-day mortality (odds ratio, 2.35; 95% confidence
interval, 1.08-5.11; P  .031).
Comment: On the surface, this report by vascular surgeons appears
almost as inflammatory as that as of Zafar et al, also abstracted in this edition
of the Journal. However, the authors of this article do a much better job of
analyzing the weaknesses of the database used and a much better job
speculating about the implications of the data. Multispecialty participation
may reflect institutional protocols, complexity of the procedure, and relative
j
(xperience of the individual operators. None of these factors can be ad-
ressed well by the National Surgical Quality Improvement Participant use
ata file.
urvival in Patients With Poorly Compressible Leg Arteries
rain FA, Ye Z, Bailey KR, et al. J Am Coll Cardiology 2012;59:400-7.
Conclusion: Patients identified by noninvasive vascular testing to have
oorly compressible arteries (PCA) in the leg have worse survival than
atients with a normal ankle-brachial index (ABI) or those with peripheral
rterial disease (PAD).
Summary: The National Health and Nutrition Examination Survey
uggests 1.6 million adults aged40 years in the United States have an ABI
1.4 (Resnick HE et al, Am J Med 2005;118:676-9). Three studies have
ndicated community-dwelling volunteers with elevated ABIs have survival
ates similar to those with PAD (ABI 0.9). In this study, the authors
ought to compare patients with PCA, who were identified in a noninvasive
ascular laboratory, with patients with a normal ABI as well as with patients
ith PAD. Comparisons were made in prevalence of cardiovascular risk
actors, comorbid conditions, and survival. This was a historical cohort study
f consecutive patients who underwent outpatient noninvasive lower ex-
remity arterial evaluation at the Mayo Clinic in Rochester, Minnesota, from
anuary 1998 through December 2007. Patients were followed up for a
ean duration of 5.8  3.1 years. An ABI of 1.00 to 1.30 was considered
ormal. PAD was defined as a resting or postexercise ABI of 0.90. PCAs
ere defined as an ABI 1.4 or an ankle systolic blood pressure 255 mm
g or both. Follow-up was for all-cause mortality through September 30,
009. There were 16,493 individuals (59% men) evaluated with a mean age
f 67.8 13.0 years. Of these patients, 29% had a normal ABI, 54% met the
efinition for PAD, and 17% had PCAs. During a mean follow-up of 5.8 
.1 years 4365 patients (26%) died. At the end of the study period, the
ercentages alive were 88%, 70%, and 60% in cohorts with a normal ABI,
AD, and PCA, respectively. After adjustment for age, sex, comorbid
onditions, cardiovascular risk factors, and medications, the hazard ratios of
eath associated with PCA were 2.0 (95% confidence interval, 1.8-2.2) and
.3 (95% confidence interval, 1.2-1.4) compared with the normal ABI and
AD groups, respectively.
Comment: There were 2,781 patients with poorly compressible arter-
es in this series, the largest cohort of such patients to be studied and
ollowed up. Nevertheless, the study cohort was almost entirely non-
ispanic white, and therefore, it may be difficult to generalize the findings to
ther racial and ethnic groups. It is unclear whether PCAs are a marker of
ncreased risk or directly contribute to increased mortality. Greater arterial
tiffness in patients with PCAs may lead to higher blood pressure and
ubsequently greater left ventricular mass. Serum N-terminal pro-B-type
atriuretic peptide levels are higher in patients with PCA than in those with
ormal ABI and PAD (Jouni H et al, Atheroscler Thromb Vasc Biol
011;31:197-202), suggesting a greater underlying component of heart
isease in patients with PCAs. Whether PCAs are causing heart disease or are
“fellow traveler” of advanced atherosclerosis is unknown.
horacic or Thoracoabdominal Approaches to Endovascular Device
emoval and Open Aortic Repair
eMaire SA, Green SY, Kim JH, et al. Ann Thorac Surg 2012;93:726-33.
Conclusion:Open surgical repair for failed endovascular aortic proce-
ures performed through thoracic or thoracoabdominal approaches is suc-
essful in most patients, provided the device is not infected.
Summary: It is now quite evident, unfortunately, that devices placed
or endovascular repair of aortic aneurysms must occasionally be removed
ith open surgical techniques. This may be due to aneurysm expansion
econdary to endoleak, aortic rupture, and on occasion, infection of the stent
raft. A number of case series describe removal of abdominal devices
hrough abdominal incisions. Although the frequency of open conversion is
ifficult to determine, it does appear with placement of more devices and
lacement of devices outside the instructions for use provided by the
anufacturer, that open removal of endovascular aortic devices is becoming
ore frequent. The literature suggests that rates of late open conversion
ange from 2.2% to 6.2% for thoracic endovascular aneurysm repair and from
.9% to 2.4% for EVAR.
The authors report a relatively large series of 35 patients undergoing
epair via a thoracic or thoracoabdominal approach for a failed endovascular
evice. Open aortic repair was preformed through thoracotomy (n  7) or
horacoabdominal incision (n 28) from 0.5 to 48months after the original
ndovascular thoracic (n  27) or abdominal (n  8) aortic procedure.
pen repair was indicated for expanding aneurysm in 23 patients, infection
f the device in eight, fistula in five, pseudoaneurysm in two, aneurysm
upture in two, and restenosis in one. A device was partially removed in nine
atients and completely removed in 26. The authors preformed thoracic
ortic repair in 10 patients, thoracoabdominal aortic repair in 24, and
uxtarenal abdominal aortic repair in one. There were two in-hospital deaths
6%). Both deaths occurred in patients with endovascular device infection.
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Volume 56, Number 2 Abstracts 575There were also eight late deaths. One-year survival was 83%  7%. Among
patients with infected endovascular devices, three experienced major late
complications (persistent infection, pseudoaneurysm, and recurrent fistula),
and two of these patients died.
Comment: This is a large series of complex procedures performed for
failure of endovascular abdominal or thoracic aortic devices. Case series of
open removal of endovascular devices seem to be appearing more frequently
as more of these devices are implanted. It is notable that the devices in 71%
of the patients in this series were implanted for off-label indications. Sixty
percent of the patients had been treated for aortic dissection. It also should
be noted that if the device is not infected, the patients can do well with open
removal. However, as whole, patients with infected devices and those with
devices placed for control of fistula have a poor prognosis.
Usefulness of Pre-Operative Copeptin Concentrations to Predict Post-
Operative Outcome After Major Vascular Surgery
Jarai R, Mahla E, Perkmann T, et al. Am J Cardiol 2011;108:1188-95.
Conclusion: Copeptin is a new biomarker that potentially improves
prediction of perioperative and postoperative outcomes in vascular surgery
patients.
Summary: The revised cardiac risk index, the so-called Lee index, is
used widely to determine preoperative risk of surgical patients (Lee TH et al,
Circulation 1999;100:1043-49). Arginine vasopressin (AVP), an antidi-
uretic hormone, is important in the regulation of cardiovascular homeosta-
sis. It also affects platelet aggregation and release of von Willebrand factor
(Katan M et al, Crit Care 2008;12:117). Many factors play a role in
perioperative myocardial infarction, including hypertension, platelet aggre-
gation, fibrinolytic activity, and hypercoagulability. Some of these are influ-
enced by AVP. The authors postulate enhanced AVP secretion before
surgery could potentially make patients susceptible to perioperative myocar-
dial events; however, for a variety of reasons, AVP itself is unsuitable as a
biomarker for routine clinical practice. The C-terminal fragment of the
provasopressin peptide, copeptin, is secreted in equimolar amounts with
t
rVP. Copeptin can be reliably determined with a chemiluminescence assay
Morgenthaler NG et al, Clin Chem 2006;52:112-9). The purpose of this
eport was to determine whether copeptin levels the day before elective
ascular surgery identified high-risk patients. There were 189 consecutive
atients who underwent major vascular surgery. Infrainguinal reconstruc-
ions accounted for 58.6%, abdominal aortic aneurysm surgery for 23.7%,
nd carotid endarterectomy for 17.7%. In-hospital and 2-year major cardiac
dverse event rates (cardiac death, nonfatal myocardial infarction, emer-
ency coronary revascularization) were monitored. Forty patients (20.2%)
eached the primary end point. Most events occurred during the index
ospital stay, 45%. By univariate analysis, increasing concentrations of co-
eptin as a continuous variable were significant determinants of outcome
hazard ratio [HR], 1.012; P  .005) and as a dichotomized variable using
he recommended cutoff of 14.0 pmol/L (HR, 4.116; P  .001). Patients
t low estimated risk according to N-terminal pro-B-type natriuretic peptide
NT-pro-BNP) levels were at a significantly higher risk for worse outcomes
ith higher copeptin levels (HR, 5.983; P  .002). Multivariate Cox
egression analysis demonstrated copeptin concentrations 14 pmol/L
ere independent predictors of outcome (HR, 2.842; P  .002). This was
n addition to type of surgery, history of myocardial infarction, and eleva-
ions of cardiac troponin T and NT-pro-BNP levels. Higher copeptin levels
ere additive to the Lee index (14 pmol/L; HR, 4.059; 95% confidence
nterval, 2.18-7.57; P  .001) and to the Eagle score (HR, 3.26; 95%
onfidence interval, 1.72-6.17; P  .001) for estimating postoperative
utcomes.
Comment: There is the possibility, because of the small number of
atients in this study, the authors actually underestimated the association of
opeptin concentrations with cardiac events after major vascular surgery. It
ollows they may also underestimate the additional predictive value of
opeptin concentrations to more established risk factor assessment, such as
he Lee index, NT-pro-BNP, and Eagle criteria. In addition, patients
ntered this study between 2002 and 2003, and techniques of anesthesia and
ascular surgery have changed significantly since then. The authors’ results,
herefore, while interesting, need confirmation in a larger more contempo-
ary population of vascular surgical patients.
